phrykt

Incyte (INCY) revenue: $5.1B

Incyte reported $5.1B of revenue for the year ended Dec 31, 2025, up 21.2% from $4.2B a year earlier.

From Incyte's filings with the SEC · Read the filing · INCY stock page

Incyte revenue by year

$3B2021$3.4B2022$3.7B2023$4.2B2024$5.1B2025

#684 of 3,622 US companies by revenue · See the full ranking

Year endedRevenueChange
Dec 31, 2025$5.1B+21%
Dec 31, 2024$4.2B+15%
Dec 31, 2023$3.7B+9%
Dec 31, 2022$3.4B+14%
Dec 31, 2021$3B–

Revenue of similar companies

Companies in the same industry as Incyte, by SEC industry code, with the closest revenue. Each name opens the same page for that company.

CompanyRevenue, latest yearYear ended
Iqvia$16.3BDec 31, 2025
Icon$8.3BDec 31, 2025
Incyte$5.1BDec 31, 2025
Charles River Laboratories International$4BDec 27, 2025
Medpace Holdings$2.5BDec 31, 2025
OmniAb$18.7MDec 31, 2025
Absci$2.8MDec 31, 2025

Questions and answers

What is Incyte's revenue?

Incyte reported $5.1B of revenue for the year ended Dec 31, 2025, up 21.2% from $4.2B a year earlier.

Numbers as reported in Incyte's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology